Cisplatin Dose Rate and Nephrotoxicity in Children
Author Information
Author(s): R Skinner, ADJ Pearson, MW English, L Price, RA Wyllie, MG Coulthard, AW Craft
Primary Institution: Sir James Spence Institute of Child Health, University of Newcastle upon Tyne
Hypothesis
Does the dose rate of cisplatin affect the incidence and severity of nephrotoxicity in children?
Conclusion
Cisplatin nephrotoxicity is more severe in children receiving higher dose rates, but some recovery of kidney function occurs over time.
Supporting Evidence
- 58% of children had a GFR below the normal range.
- 29% of children were hypomagnesaemic after treatment.
- Nephrotoxicity scores were significantly lower in children receiving lower dose rates of cisplatin.
Takeaway
This study found that giving cisplatin at a slower rate is better for kids' kidneys. Even though some kids got better, we still don't know how long the kidney problems might last.
Methodology
The study measured glomerular filtration rate (GFR) and tubular function in children after cisplatin chemotherapy, comparing those who received low and high dose rates.
Limitations
The long-term outcomes of nephrotoxicity remain unknown, and the study had a limited follow-up period.
Participant Demographics
Children aged 0.6 to 17.8 years, with various types of cancers including neuroblastoma and brain tumors.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website